Stephen Connelly, President and Chief Scientific Officer, on June 04, 2026, sold 230,975 shares in Equillium (EQ) for $723,830. Following the Form 4 filing with the SEC, Connelly has control over a total of 762,025 common shares of the company, with 762,025 shares held directly.
SEC Filing: